Diabetic neuropathy: mechanisms to management
JL Edwards, AM Vincent, HT Cheng… - Pharmacology & …, 2008 - Elsevier
Neuropathy is the most common and debilitating complication of diabetes and results in
pain, decreased motility, and amputation. Diabetic neuropathy encompasses a variety of …
pain, decreased motility, and amputation. Diabetic neuropathy encompasses a variety of …
[图书][B] Handbook of eHealth evaluation: an evidence-based approach
F Lau, C Kuziemsky - 2016 - dspace.library.uvic.ca
This handbook presents the science and practice of eHealth evaluation based on empirical
evidence gathered over many years within the health informatics discipline. The handbook …
evidence gathered over many years within the health informatics discipline. The handbook …
Diabetic foot care: knowledge and practice
A Pourkazemi, A Ghanbari, M Khojamli, H Balo… - BMC endocrine …, 2020 - Springer
Abstract Background Diabetic foot ulcers (DFUs) are common problems in diabetes. One of
the most important factors affecting the quality of diabetes care is knowledge and practice …
the most important factors affecting the quality of diabetes care is knowledge and practice …
The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial
OBJECTIVE Continuous glucose monitoring (CGM) improves glycemic control, but data are
inconclusive about its influence on quality of life (QOL). We investigated the impact of 24 …
inconclusive about its influence on quality of life (QOL). We investigated the impact of 24 …
First-line therapy for type 2 diabetes with sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study
Background: Guidelines recommend sodium–glucose cotransporter-2 (SGLT2) inhibitors
and glucagon-like peptide-1 (GLP1) receptor agonists as second-line therapy for patients …
and glucagon-like peptide-1 (GLP1) receptor agonists as second-line therapy for patients …
“Stay at Home, Protect the National Health Service, Save Lives”: A cost benefit analysis of the lockdown in the United Kingdom
DK Miles, M Stedman, AH Heald - International Journal of …, 2021 - Wiley Online Library
Introduction The COVID‐19 pandemic has transformed lives across the world. In the UK, a
public health driven policy of population “lockdown” has had enormous personal and …
public health driven policy of population “lockdown” has had enormous personal and …
Living with COVID-19: balancing costs against benefits in the face of the virus
D Miles, M Stedman, A Heald - National Institute Economic Review, 2020 - cambridge.org
This paper analyses the costs and benefits of lockdown policies in the face of COVID-19.
What matters for people is the quality and length of lives and one should measure costs and …
What matters for people is the quality and length of lives and one should measure costs and …
Lifetime risk for diabetes mellitus in the United States
KMV Narayan, JP Boyle, TJ Thompson, SW Sorensen… - Jama, 2003 - jamanetwork.com
ContextAlthough diabetes mellitus is one of the most prevalent and costly chronic diseases
in the United States, no estimates have been published of individuals' average lifetime risk …
in the United States, no estimates have been published of individuals' average lifetime risk …
[HTML][HTML] Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
BACKGROUND For people with diabetes mellitus to achieve optimal glycaemic control,
motivation to perform self-management is important. The research team wanted to determine …
motivation to perform self-management is important. The research team wanted to determine …
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a …
RM Bergenstal, C Wysham, L MacConell, J Malloy… - The Lancet, 2010 - thelancet.com
Background Most patients with type 2 diabetes begin pharmacotherapy with metformin, but
eventually need additional treatment. We assessed the safety and efficacy of once weekly …
eventually need additional treatment. We assessed the safety and efficacy of once weekly …